A Medical Device Daily
Matria Healthcare (Marietta, Georgia) reported the completion of its previously reported planned acquisition of CorSolutions Medical (Rosemont, Illinois), a provider of disease management and health and productivity services to employers, health plans and government-sponsored healthcare programs.
The consideration for the CorSolutions buy, first disclosed last month, was $445 million via an all-cash transaction (Medical Device Daily, Dec. 16, 2005).
“The combination of Matria and CorSolutions creates the industry's most expansive and integrated offering of wellness, health and productivity, and disease management programs,“ said Parker Petit, Matria's chairman and CEO.
Matria is a provider of comprehensive health enhancement programs to health plans and employers.
Animas (West Chester, Pennsylvania) reported that it would hold a special meeting of stockholders on Feb. 17 to vote on a proposal to approve the previously disclosed merger agreement between it, Johnson & Johnson (J&J; New Brunswick, New Jersey) and Emerald Merger Sub, a wholly owned subsidiary of J&J.
Stockholders of record as of Jan. 23 will be entitled to vote and will be mailed a definitive proxy statement in connection with the meeting.
Last month, Animas reported that it had entered into a definitive agreement to be acquired by J&J for $518 million in cash (MDD, Dec. 19, 2005).
Animas is a maker of insulin infusion pumps and related products.